If GNBT Qs being fielded: Excellagen - How do you plan to roll out Excellagen sales within the VA, given the difficulties in the rollout due to CV? What is the plan for the rollout outside the VA assuming funding through one of the funding avenues, and when will a sales forecast for our only currently viable product be put forward?

If issues persist with funding, how will Excellagen be rolled out without funding? From previous statements you have made, this product would appear to have margins which would make it a very good candidate for self-funding through the sales ramp up. Patents are aging, yet we are still not capitalizing on this product’s potential, both for its own sake and also it’s potential to fund other initiatives.